Campbell's Path to Sustained Recovery Uncertain, UBS Says

MT Newswires Live09-05 02:54

Campbell's (CPB) 2027 outlook appears achievable on relatively measured assumptions, but continued pressure and uncertainty around underlying demand make it difficult to view the setup as fully de-risked, UBS Securities said.

The company expects 2027 organic sales to decline 2% to 4% and adjusted EPS of $1.65 to $1.80, below Street expectations of $1.83.

UBS said in a note Thursday the lower bar should limit the risk of another meaningful reset, but a meaningful portion of the second-half improvement depends on cost savings and pricing initiatives.

The investment firm said the key question is whether those actions can drive sustained improvement exiting 2027 and into 2028.

UBS maintained its sell rating on the stock and raised its price target to $19 from $18.

Shares of Campbell's were down 3% in Friday trading.

Price: 21.46, Change: -0.67, Percent Change: -3.03

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment